AUD 0.02
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2024 | 2.1 Million NZD | 26.78% |
2023 | 1.66 Million NZD | -0.94% |
2022 | 1.67 Million NZD | 48.19% |
2021 | 1.13 Million NZD | -12.08% |
2020 | 1.28 Million NZD | -39.88% |
2019 | 2.14 Million NZD | 166.52% |
2018 | 804.06 Thousand NZD | 37.36% |
2017 | 585.38 Thousand NZD | 24.0% |
2016 | 472.1 Thousand NZD | -70.02% |
2015 | 1.57 Million NZD | 5329.6% |
2014 | 29 Thousand NZD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 580.83 Thousand NZD | 9.1% |
2024 Q3 | 720.28 Thousand NZD | 24.01% |
2024 FY | 2.1 Million NZD | 26.78% |
2024 Q2 | 580.83 Thousand NZD | 0.0% |
2024 Q4 | 720.28 Thousand NZD | 0.0% |
2023 Q2 | 506.97 Thousand NZD | 0.0% |
2023 Q3 | 532.39 Thousand NZD | 5.01% |
2023 Q1 | 506.97 Thousand NZD | -21.67% |
2023 FY | 1.66 Million NZD | -0.94% |
2023 Q4 | 532.39 Thousand NZD | 0.0% |
2022 Q4 | 647.23 Thousand NZD | 0.0% |
2022 FY | 1.67 Million NZD | 48.19% |
2022 Q3 | 647.23 Thousand NZD | 3.21% |
2022 Q2 | 627.09 Thousand NZD | 0.0% |
2022 Q1 | 627.09 Thousand NZD | 27.46% |
2021 Q1 | 495.05 Thousand NZD | 17.13% |
2021 FY | 1.13 Million NZD | -12.08% |
2021 Q2 | 495.05 Thousand NZD | 0.0% |
2021 Q4 | 491.99 Thousand NZD | 0.0% |
2021 Q3 | 491.99 Thousand NZD | -0.62% |
2020 Q3 | 422.64 Thousand NZD | -50.28% |
2020 Q2 | 850.05 Thousand NZD | 0.0% |
2020 FY | 1.28 Million NZD | -39.88% |
2020 Q4 | 422.64 Thousand NZD | 0.0% |
2020 Q1 | 850.05 Thousand NZD | 44.27% |
2019 Q3 | 589.2 Thousand NZD | -38.43% |
2019 Q1 | 956.94 Thousand NZD | 19.71% |
2019 Q2 | 956.94 Thousand NZD | -0.0% |
2019 Q4 | 589.2 Thousand NZD | 0.0% |
2019 FY | 2.14 Million NZD | 166.52% |
2018 FY | 804.06 Thousand NZD | 37.36% |
2018 Q3 | 799.4 Thousand NZD | 185.84% |
2018 Q4 | 799.4 Thousand NZD | 0.0% |
2018 Q1 | 279.66 Thousand NZD | -1.35% |
2018 Q2 | 279.66 Thousand NZD | -0.0% |
2017 Q2 | 405.49 Thousand NZD | -0.0% |
2017 Q4 | 283.5 Thousand NZD | 0.0% |
2017 FY | 585.38 Thousand NZD | 24.0% |
2017 Q3 | 283.5 Thousand NZD | -30.09% |
2017 Q1 | 405.49 Thousand NZD | 10.89% |
2016 Q1 | 455.74 Thousand NZD | -49.33% |
2016 FY | 472.1 Thousand NZD | -70.02% |
2016 Q3 | 365.67 Thousand NZD | -19.76% |
2016 Q4 | 365.67 Thousand NZD | 0.0% |
2016 Q2 | 455.74 Thousand NZD | 0.0% |
2015 Q2 | 208.34 Thousand NZD | -0.0% |
2015 Q3 | 899.43 Thousand NZD | 331.71% |
2015 FY | 1.57 Million NZD | 5329.6% |
2015 Q4 | 899.43 Thousand NZD | 0.0% |
2015 Q1 | 208.34 Thousand NZD | 0.0% |
2014 FY | 29 Thousand NZD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
4DMedical Limited | 3.75 Million AUD | 43.855% |
Adherium Limited | 840.98 Thousand AUD | -150.64% |
Aroa Biosurgery Limited | 63.35 Million AUD | 96.673% |
Atomo Diagnostics Limited | 4.08 Million AUD | 48.42% |
Anteris Technologies Ltd | 4.11 Million AUD | 48.728% |
Control Bionics Limited | 5.12 Million AUD | 58.887% |
CardieX Limited | 10.9 Million AUD | 80.672% |
Compumedics Limited | 49.71 Million AUD | 95.76% |
Cochlear Limited | 2.25 Billion AUD | 99.907% |
CleanSpace Holdings Limited | 15.72 Million AUD | 86.593% |
Cyclopharm Limited | 27.13 Million AUD | 92.233% |
EMVision Medical Devices Ltd | 11.21 Million AUD | 81.212% |
Nova Eye Medical Limited | 23.32 Million AUD | 90.963% |
HeraMED Limited | 402.89 Thousand AUD | -423.171% |
Imricor Medical Systems, Inc. | 615.56 Thousand AUD | -242.422% |
ImpediMed Limited | 10.31 Million AUD | 79.573% |
InhaleRx Limited | 1.2 Million AUD | -75.063% |
LBT Innovations Limited | 1.25 Million AUD | -67.822% |
Micro-X Limited | 15.22 Million AUD | 86.153% |
Neurotech International Limited | 1963.00 AUD | -107278.451% |
OncoSil Medical Limited | 1.56 Million AUD | -34.653% |
PolyNovo Limited | 103.19 Million AUD | 97.957% |
Respiri Limited | 456.91 Thousand AUD | -361.321% |
SomnoMed Limited | 91.65 Million AUD | 97.7% |
Universal Biosensors, Inc. | 6.63 Million AUD | 68.221% |
Uscom Limited | 3.72 Million AUD | 43.442% |
Visioneering Technologies, Inc. | 8.67 Million AUD | 75.688% |